Work

A comparison of non-toxin vaccine adjuvants for their ability to enhance the immunogenicity of nasally-administered anthrax recombinant protective antigen

Year: 2013

Type: article

Source: Vaccine

DOI: 10.1016/j.vaccine.2013.01.012

Authors: William M. Gwinn, Brandi T. Johnson, Shaun M. Kirwan, Ashley E. Sobel, Soman N. Abraham, Michael D. Gunn, Herman F. Staats

Institution: Duke Medical Center

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Heart, Lung, and Blood Institute, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: Novel TLR Ligand Mimetics as Adjuvants and Therapeutics, Medical Scientist Training Program, Immune mediated exocytosis of intravesicular UPEC from bladder cells, Mast Cell Activator as Adjuvant for Biodefense Vaccines, Mast Cells in Dengue Pathology and Prevention, Nasal Vaccines: Mode of Action, Composition & Delivery

OpenAlex ID: W2002159011

FWCI: 1.311

Cites: 49

Cited by: 27

Related to: 10